ACIU acimmune.com Net earnings per share growth this year
The shift in year-over-year EPS metrics on this GURU.Markets system chart for AC Immune (ACIU) exhibits volatility due to the concentration on Alzheimer's therapy and binary pipeline risks, where 44.90 becomes the new metric value. Capital stability is supported by payments from global partners, while growth potential is based on innovative antibody platforms designed to combat pathological brain proteins.
Financial and market metric breakdowns for AC Immune (ACIU)
- price and consensus price forecast:
- market capitalization data:
- company book value details:
- debt and solvency information:
- earnings and market multiples details:
ACIU - Company Net Income|Net Profit Forecast AC Immune|ACIU - P/E Multiple|Projected Price to Earnings Ratio AC Immune Inc|ACIU - Price/Earnings to Growth Multiple|EV/EBITDA Multiple AC Immune Inc|ACIU - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year AC Immune|ACIU - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months acimmune.com|ACIU - Earnings growth in current year|Earnings growth forecast for next year AC Immune
Fundamental valuation:ACIU, AC Immune S.A.
Year-over-year EPS (earnings per share) dynamics measure the rate of change in net income, allowing for an assessment of the business's fundamental stability relative to its market sector. The current chart level of annual EPS growth stands at 44.90, which is critical for AC Immune (ACIU), as high R&D expenses in the absence of revenue lead to a systematic depletion of reserves and a dependence on external capital.
Direct competitors
Net earnings per share growth this year Biogen Inc|Earnings per share growth in current year Neurocrine Biosciences Inc|Net earnings per share growth this year Regencell Corp (RGC)|Net earnings per share growth this year AXSM (Axsome Therapeutics)|Earnings growth in current year acadia-pharm.com (ACAD)|Earnings per share growth in current year Xenon XENE|VKTX: Earnings per share growth this year|Supernus Pharma - Earnings growth in current year|Earnings per share growth rate in current year Catalyst Corp|DNLI: Earnings growth in current year|harmonybiosciences.com (HRMY) - Earnings growth in current year|BHVN (Biohaven) - Earnings growth in current year|Net earnings per share growth this year Amylyx Pharmaceuticals Inc (AMLX)|Earnings growth in current year TRVI|Expected net earnings per share growth this year Praxis Corp|Anavex Life Sciences - Net earnings per share growth this year|Earnings growth in current year ceribell.com CBLL|PRTA - Earnings per share growth in current year|ALEC (Alector, Inc.) - Earnings per share growth this year|ANNX: Earnings growth in current year|Earnings per share growth rate in current year Omeros (OMER)|Net earnings per share growth this year NGNE|Earnings growth in current year voyagertherapeutics.com|Earnings per share growth in current year Neumora Therapeutics, Inc. (NMRA)|SCLX (Scilex Holding) - Earnings per share increase in current year|Earnings per share growth in current year Tevogen Bio Holdings, Inc. TVGN|Alpha Cognition Inc (ACOG) - Earnings per share growth rate in current year|Cognition Therapeutics, Inc. - Earnings growth in current year|IKT - Earnings growth in current year|SAVA: Earnings growth in current year|Net earnings per share growth this year Assertio|Net earnings per share growth this year COYA|VTGN: Earnings per share increase in current year|Earnings growth in current year OVID|Expected net earnings per share growth this year acumenpharm.com|Earnings per share growth in current year CervoMed CRVO|ATHE - Net earnings per share growth this year|CLNN - Earnings per share growth in current year|PepGen Inc. (PEPG) - Net earnings per share growth this year|JUNS (Jupiter Neurosciences) - Net earnings per share growth this year|relmada.com (RLMD) - Earnings growth in current year|Earnings per share growth in current year Annovis Bio|Earnings per share growth this year GRCE (Grace Tx)|Earnings growth in current year AIFF|KLTO - Earnings per share growth rate in current year|Earnings growth in current year NRSN (NeuroSense Therapeutics Ltd.)|Earnings growth in current year revivapharma.com RVPH|MetaVia, Inc. - Earnings growth in current year|NeurAxis Inc. (NRXS) - Net earnings per share growth this year|HSDT: Earnings growth in current year|PASG - Expected net earnings per share growth this year|Net earnings per share growth this year NEUP|Earnings growth in current year minervaneurosciences.com|Earnings per share growth in current year Athira Pharma (ATHA)|Addex Therapeutics Ltd. - Earnings per share growth this year|Earnings growth in current year ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Earnings per share growth rate in current year|PTIX: Net earnings per share growth this year|KTTA - Earnings growth in current year|cortigent.com (CRGT) - Earnings per share growth in current year|Avenue Therapeutics Inc. - Earnings per share increase in current year|Earnings per share growth in current year Brainstorm Cell Therapeutics, Inc.|Earnings per share growth rate in current year Cara Therapeutics Inc CARA|Earnings growth in current year CHRO|Earnings growth in current year eliemtx.com (ELYM)|Earnings growth in current year ITCI (Intra-Cellular Therapies, Inc.)|LBPH - Net earnings per share growth this year|MRNS: Net earnings per share growth this year|Earnings per share increase in current year NKGN (NKGen Biotech Corp)|NRBO: Earnings growth in current year|SAGE - Expected net earnings per share growth this year|Earnings per share growth in current year Synaptogenix|Net earnings per share growth this year Trevena Inc. (TRVN)|Earnings per share growth in current year Vigil Neuroscience (VIGL)|Net earnings per share growth this year anewmeds.com WENA|Cerevel Therapeutics - Net earnings per share growth this year
